Chrastil-LaTowsky Brenda, Wesley Naissan O, MacGregor Jennifer L, Kaminer Michael S, Arndt Kenneth A
SkinCare Physicians, 1244 Boylston St, Ste 103, Chestnut Hill, MA 02467, USA.
Arch Dermatol. 2009 Nov;145(11):1309-12. doi: 10.1001/archdermatol.2009.266.
Given the recent boom of the cosmetic industry, there is a wealth of new products available to patients and physicians, including soft-tissue fillers. Bio-Alcamid polyacrylamide gel (Polymekon, Milan, Italy) is a filler that has potential to cause adverse reactions.
Two patients who had previously been treated with Bio-Alcamid outside of the United States presented with different manifestations of inflammatory responses to the product. These reactions were challenging to treat.
Despite claims of safety, Bio-Alcamid and possibly other soft-tissue fillers available worldwide have the potential to cause adverse reactions. Physicians should be aware of the various presentations and treatment options for these reactions.
鉴于近期美容行业的蓬勃发展,患者和医生可以获得大量新产品,包括软组织填充剂。生物聚酰胺聚丙烯酰胺凝胶(Polymekon,意大利米兰)是一种可能引起不良反应的填充剂。
两名此前在美国境外接受过生物聚酰胺治疗的患者出现了对该产品不同表现的炎症反应。这些反应治疗起来颇具挑战性。
尽管声称安全,但生物聚酰胺以及全球范围内可能的其他软组织填充剂都有引起不良反应的可能性。医生应了解这些反应的各种表现形式和治疗选择。